MarketInOut Stock Screener Log In | Sign Up
 

Burning Rock Biotech Ltd ADR

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/23/2026
Burning Rock Biotech Ltd ADR stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization139.74 mln
Float8.76 mln
Earnings Date11/17/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.32
Borderline

Relative Strength

10 / 100
Significantly lagging

Debt / Equity

0.09
Debt-free

Pre-Tax Margin

-13%
Loss-making

ROE

-12.80
Negative

Business Description

Burning Rock Biotech, founded in 2014 and based in Guangzhou, China, develops advanced genetic testing tools that help doctors choose the right cancer treatments for their patients. The company serves hospitals, independent laboratories, and pharmaceutical companies across China and the United States, offering tests that analyze tumor DNA from both tissue and blood samples across a wide range of cancer types. It also partners with major global pharmaceutical companies to support clinical trials and drug development research.

Key Fundamentals

EPS-0.80
ROE-12.80
RPS69.11
ROIC-25.50
ROA-8.52
Interest Cover-1,084
EBITDA, mln-6.53
EV / EBITDA-17.93
EV / EBIT-12.33
Revenue, mln71.59
EV / Revenue1.64

Quote Details

Last 11.82
Change -1.43 (-10.79%)
Open 13.51
Volume 51,515
Turnover 608,907
Average Volume 30,929

Financial Ratios

Pre-Tax Profit Margin-13
Leverage Ratio1.51
Current Ratio3.03
Price / Book2.11
Price / Tangible Book2.12
Debt / Equity0.09
Price / Sales2.62

Financial Strength

Altman Z-Score-4.26
Piotroski F-Score 4 / 9
Beneish M-Score-2.32
Short Ratio0.66
Short % of Float0.58

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -8.37% 11 / 100   
1 Month -34.33% 9 / 100   
2 Months 18.56% 92 / 100   
6 Months -42.59% 15 / 100   
1 Year 16.45% 76 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog